{Synthesis, characterization and antimicrobial activity of benzofuran and thiophene substituted novel diketoxime derivatives} J. Serb. Chem. Soc. 82 (4) 367–377 (2017) UDC 547.728.1+547.73+542.913: JSCS–4972 547.442.2:615.28–188 Original scientific paper 367 Synthesis, characterization and antimicrobial activity of novel benzofuran- and thiophene-containing diketoxime derivatives DEMET COSKUN1*, SEHER GUR2 and MEHMET FATİH COSKUN1 1University of Fırat, Faculty of Science, Department of Chemistry , 23119 Elazığ-Turkey and 2University of Fırat, Faculty of Science, Department of Biology , 23119 Elazığ-Turkey (Received 17 May, revised 24 November, accepted 14 December 2016) Abstract: The aim of this study was the preparation of 1,1′-(2,5-thiophene- diyl)bis[1-(2-benzofuranyl)methanone] (2), the corresponding diketoxime (3), and the ether and ester derivatives (4a–e) of the diketoxime. These compounds were prepared in good yields. Minimum inhibitory concentrations (MIC) of the synthesized compounds 1–4 were determined against Salmonella enterica subsp. enterica serovar Typhimurium, Escherichia coli and Staphylococcus aureus. Among the synthesized compounds, 1 and 4e showed good activity against E. coli, S. enterica and S. aureus. Keywords: bisbenzofuran; thiophene; diketoxime; antimicrobial activity. INTRODUCTION Benzofuran derivatives are an interesting class of heterocyclic compounds. Many benzofuran derivatives find application in several fields, including as anti- oxidants, brightening agents, a fluorescent sensor1 and other fields of chemistry.2 Benzofuran derivatives form a number of natural products, such as bergapten, nodakenetin, xanthotoxin and khellin (Fig. 1). Fig. 1. Several benzofuran derivatives: a) khellin; b) bergapten; c) nodakenetin; d) xanthotoxin. Thiophene and its derivatives exhibit interesting biological activities and considerable electroluminescent properties.3,4 These compounds have been used * Corresponding author. E-mail: dcoskun@firat.edu.tr doi: 10.2298/JSC160517003C 368 COSKUN, GUR and COSKUN as fluorescent markers and sensors in energy transfer and light-harvesting sys- tems.5 The diketoxime derivatives are very important model systems in applied chemistry. In general, they are used in medicine, photography, agriculture, textiles, dye chemistry and the manufacture of semiconductors. Furthermore, they are also used as biological model compounds (i.e., vitamin B12).6–12 Accordingly, the antibacterial and antifungal activities of oxime derivatives have been well explored.13–20 Various heterocyclic-substituted oxime ethers were extensively studied due to their diverse biological properties.21 Oxime ethers are used as anti-inflammatory drugs,22,23 β-adrenergics,24 mild inhibitory active compounds in poultry science25 and as various materials with steroidal effects.26 The biological activities of the oxime ether pharmacophore –C=N–O–R is also well documented.27 However, studies in the literature con- cerning bisbenzofuran-containing oxime compounds are limited. Due to the applications of benzofuran, thiophene and diketoxime derivatives mentioned above, it was decided to design new benzofuran- and thiophene-based systems consisting of functionalized diketoxime. The aim of this study was the synthesis of 1,1′-(2,5-thiophenediyl)bis[1-(2- -benzofuranyl)methanone], its dioxime derivative, and new reaction products of the dioxime derivative with various acyl and alkyl halides. In addition, the anti- microbial behavior of all the synthesized compounds was investigated. EXPERIMENTAL All the chemicals were supplied from Sigma–Aldrich and used without further purific- ation. Melting points were measured using a differential scanning calorimeter (Shimadzu DSC-50) and are uncorrected. The NMR spectra were determined on a Bruker AC 400 (400 MHz) spectrometer, with tetramethylsilane (TMS) as the internal standard in DMSO-d6 or CDCl3 as solvents. The FT-IR spectra were recorded as KBr pellets on a Perkin–Elmer Spectrum One FTIR spectrometer. The synthesis scheme to compounds 1–4 is presented in Fig. 2, whereas analytical and spectral data are given in Supplementary material to this paper. Synthesis of compounds 1–3 The required starting material 2-acetylbenzofuran was obtained by cyclocondensation reaction. Currently, several general methods are known for the preparation of 2-acetylben- zofuran.28 1-(Benzofuran-2-yl)-2-bromoethanone was obtained by reaction of 2-acetylbenzofuran with bromine in acetic acid, according to the general procedure described in the literature,29 with slight modifications. The new diketo sulfide (1) and its 2,5-diacylthiophene derivative (2) were prepared according to the procedure described by Miyahara.30 Synthesis of 2,2'-thiobis[1-(1-benzofuranyl)ethanone] (1). A solution of sodium sulfide nonahydrate (4.80 g, 20 mmol) in 12 mL of water was added dropwise to a stirred solution of 1-(benzofuran-2-yl)-2-bromo ethanone (9.56 g, 40 mmol) in 100 mL of acetone cooled in an ice bath. Reaction mixture was stirred at room temperature for 2 h. The yellow residue was SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF DIKETOXIME DERIVATIVES 369 filtered and washed with water and methanol. The compound 1 was then recrystallized from benzene–methanol (1:3 volume ratio). Fig. 2. Synthesis to the benzofuran- and thiophene-substituted diketoxime derivatives. Synthesis of 1,1′-(2,5-thiophenediyl)bis[1-(2-benzofuranyl)methanone] (2). A solution of glyoxal was prepared by refluxing a mixture of 0.34 g (1.60 mmol) glyoxal trimer dihydrate and 10 mL of methanol and 30 mL of dioxane for 1 h under magnetic stirring. The keto sulfide (1.40 g, 4 mmol) was dissolved in the solution. A solution of sodium methoxide (0.10 g of sodium dissolved in 10 mL of methanol) was added dropwise to this solution at 40 °C. A precipitate then began to form. The mixture was stirred for 30 min. The formed solid was filtered, washed with methanol and dried. Synthesis of 1,1′-(2,5-thiophenediyl)bis[1-(2-benzofuranyl)methanone], 1,1′-dioxime (3). Compound 2 (1.00 g, 2.69 mmol), hydroxylamine hydrochloride (0.37 g, 5.38 mmol) and pyridine (50 mL) were mixed and refluxed for 24 h. After cooling to room temperature, the mixture was poured into water and the crude 3 that separated was filtered, washed with water several times and crystallized from ethanol. General procedure for the synthesis of 4a–d Triethylamine (0.07 mL, 0.5 mmol) was added to a stirred solution of 3 (0.10 g, 0.25 mmol) in 5 mL of tetrahydrofuran. The mixture was stirred at room temperature for 10 min. The appropriate acyl chloride (0.5 mmol) was added dropwise at 0 °C and the reaction mixture was stirred at room temperature for 24 h. The mixture was poured into water and the formed precipitate was filtered, dried in air and recrystallized from ethanol. Synthesis of 1,1′-(2,5-thiophenediyl)bis[1-(2-benzofuranyl)methanone], 1,1′-bis[O-(4- ethenylphenyl)methyloxime] (4e). Compound 3 (0.10 g, 0.25 mmol), K2CO3 (0.076 g, 0.55 370 COSKUN, GUR and COSKUN mmol) and the appropriate alkyl chloride (0.5 mmol) were mixed in absolute acetone and the mixture was refluxed for 5 h. After cooling to room temperature, the mixture was poured into water. The formed solid was filtered, washed with water and recrystallized from ethanol. Antibacterial assays Bacterial cultures were obtained in Mueller–Hinton broth (Difco) for Escherichia coli (ATCC 25922) Salmonella enterica subsp. enterica serovar Typhimurium (NRRL 4420) and Staphylococcus aureus (ATCC 6538) after 24 h of incubation at 37±0.1 °C. Testing for the bacteria was realized in Mueller–Hinton broth. The final inoculum size for all bacteria was 105 CFU mL-1. The test compounds were dissolved in DMSO at an initial concentration of 1024 μg mL-1 and then serially diluted to 1 μg mL-1 in culture medium. A set of tubes containing only inoculated broth served as the control. Antibacterial activity was determined after incubation for 24 h at 37 °C. The minimum inhibitory concentration (MIC) and defined as the lowest concentration of the compounds that inhibited the visible growth of a microorganism. All experiments were replicated two times to define the MIC values. RESULTS AND DISCUSSION First, 2-acetylbenzofuran was obtained in the reaction of 2-hydroxybenz- aldehyde and 1-chloroacetone. 1-(Benzofuran-2-yl)-2-bromoethanone, which was the starting material, was synthesized by bromination of 2-acetylbenzofuran with bromine in acetic acid. Treatment of this compound with hydroxylamine hydro- chloride in pyridine gave 3. Reaction of 3 with appropriate acyl chlorides in THF in the presence of tri- ethylamine gave the oxime ester compounds 4a–d. Furthermore, reaction of com- pound 3 with the appropriate alkyl chloride in acetone in the presence of K2CO3, gave the oxime ether derivative 4e. All new compounds were characterized by 1H-NMR, 13C-NMR and FT-IR spectroscopy and elemental analysis. These data are given in the Supplementary material to this paper. In FT-IR spectrum, the most important evidence of the formation 1 was the observation of two stretching vibrations at about 1663 and 1680 cm–1, belonging to the two C=O groups. Additionally, in the 1H-NMR spectrum, a signal at 4.1 ppm as a singlet belonging to –SCH2– protons and in the 13C-NMR spectrum, a signal at 185.48 ppm belonging to the C=O group proved the formation of compound 1. In the FTIR spectrum of compound 2, the C=O stretching vibration was obs- erved at 1618 cm–1. Due to conjugation, this stretching vibration shifted to a lower wave number. In the 1H-NMR spectrum of this compound, the disappear- ance of the singlet signal at 4.1 ppm, belonging to –SCH2 protons, was evidence for the formation of compound 2. In the IR spectrum of 3, while OH band of the oxime was displayed between 3000–3250 cm–1, the C=N stretching band and the N–O stretching band were seen at 1583 and at 1030 cm–1, respectively. As is known, there are three geo- metrical isomers of the dioximes due to the two oxime groups including the anti- -(E,E), amphi-(E,Z) and syn-(Z,Z) forms, which are shown in Fig. 3.31 SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF DIKETOXIME DERIVATIVES 371 Fig. 3. Geometric isomers of the symmetrically substituted dioxime 3: a) anti-(E,E), b) amphi-(E,Z) and c) syn-(Z,Z). It was expected that 3 would show two different isomeric structures. When the 1H-NMR spectrum for compound 3 was investigated, the N–OH resonances appeared as two singlets at 13.1 ppm (for the E,E isomer) and at 12.8 ppm (for the Z,Z isomer). The E isomer appeared at a higher frequency than the Z iso- mer.32–36 In the 13C-NMR spectrum of dioxime 3, twenty-four carbon signals were seen, supporting a syn- and anti-isomer mixture of compound 3. In the 13C-NMR spectrum of compound 3, the C=N signal was displayed at 153 ppm while the C=O signal had disappeared. Dioxime 3 was not expected to be in the amphi form due to different integral values belonging to the N–OH protons at 13.1 and 12.8 ppm. The different integral values belonging to the two N–OH protons con- firmed that compound 3 consisted of a syn- and anti-isomer mixture. Moreover, if the amphi-isomer were present in the mixture, more carbon peaks could be expected in the 13C-NMR spectrum. Due to molecular balancing, the molecules in the amphi-isomer structure break down. Additionally, a TLC run of a sample of the crystalline dioxime 3 was per- formed and doubled spots on the plate were observed. Therefore, it was con- cluded that the dioxime 3 consisted of a mixture of EE/ZZ isomers. Reactions of dioxime 3 with appropriate alkyl and acyl chlorides gave iso- mer mixtures that consisted of dioxime ether and dioxime ester type compounds, 4a–e. The disappearance of strong broad –OH band in the 3250–3000 cm–1 372 COSKUN, GUR and COSKUN region in the FT-IR spectrum of 4a–d and the appearance of strong bands at around 1755–1740 and 1250–1050 cm–1, which were due to C=O and C–O stretching vibrations, respectively, indicated the formation of ester products. The ester derivatives of the dioxime 4b (Fig. 4) and 4c (Fig. 5) were obtained as a mixture of anti- and amphi-forms. In the 1H-NMR spectrum of 4b, the signals of thiophene ring protons (Ha1 and Ha) in the ester unit of the amphi- -form of 4b appeared as two doublets at 7.32 (J = 3.5 and 5.1 Hz) and 7.14 (J = = 3.6 Hz and 5.8 Hz) ppm. In the 1H-NMR spectrum of 4b, the signals of the thiophene ring protons of the anti-form of 4b are probably among multiple sig- nals at 7.33–8.15 ppm. In the 1H-NMR spectrum of compound 4c, both reso- nances of the furan ring proton (Hb) belonging to the anti-isomer of 4c appeared as a singlet signal at 6.87 ppm. Signals of the Ha1 and Ha protons belonging to amphi-isomer of 4c appeared as two singlets at 6.82 and 6.63 ppm. For a sym- metrical dioxime in the anti-form, only a single peak was expected.37,38 These three values might correspond to a mixture of anti- and amphi-forms.39,40 Fig. 4. a) Amphi-(E,Z)- and b) anti-(E,E)-isomers of 4b. Fig. 5. a) Amphi-(E,Z)- and b) anti-(E,E)-isomers of 4c. The amounts of the syn-, anti- and amphi-isomers of 3 and 4c–e were calcul- ated from the integrated heights in the 1H-NMR spectra and these values are given in Table I. SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF DIKETOXIME DERIVATIVES 373 TABLE I. E,E, Z,Z and E,Z amounts, %, of 1,1′-(2,5-thiophenediyl)bis[1-(2-benzofur- anyl)methanone], 1,1′-dioxime Compound Isomer E,E Z,Z E,Z 3 55 45 – 4c 41 – 59 4d 61 39 – 4e 31 69 – The ester derivatives of the dioxime 4a, 4d and 4e (Fig. 6) were obtained as a mixture of anti- and syn-forms. In the 1H-NMR spectrum of 4d, signal of the OCH3 protons belonging to the anti-isomer of 4d was observed as a singlet sig- nal at 3.87 ppm. In addition, the signal of the OCH3 protons belonging to the syn- -isomer of 4d appeared as a singlet at 3.75 ppm. In the 1H-NMR spectrum of 4e, signals of the OCH2 protons belonging to the anti- and syn-isomer were observed as two singlets at 5.47 and 5.40 ppm, respectively. Fig. 6. a) Anti-(E,E)- and b) syn-(Z,Z)-isomers of 4e. In the 13C-NMR spectra of 4b and 4c, the 48 carbon signals prove that these dioxime derivatives consisted of anti- and amphi-isomer mixtures. Moreover, in the 13C-NMR spectra of 4a, 4d and 4e, the 34, 38 and 40 carbon signals, res- pectively, proved that these dioxime derivatives consisted of anti- and syn-isomer mixtures. The OCH3 proton signals at 3.87 ppm (anti-isomer) and 3.75 ppm (syn-iso- mer) also have good correlation with the quaternary carbon signal at 162.72 ppm in HMBC spectrum (Fig. S-7c of the Supplementary material). The 13C-signals at 56.17 ppm (anti-isomer) and 56.02 ppm (syn-isomer) give cross peaks with two OCH3 protons belonging to the anti- and syn-isomers at 3.87 and 3.75 ppm, res- 374 COSKUN, GUR and COSKUN pectively, in the HSQC spectrum (Fig. S-7d of the Supplementary material). It is clear that the signals at 56.17 and 56.02 ppm belong to the aliphatic OCH3 car- bons of anti- and syn-isomers of 4d. All these data obtained from HSQC and HMBC spectra showed that the signal at 162.72 ppm is the quaternary carbon (C-17) on the disubstituted phenyl ring. The 13C-signals at 132.59 and 132.35 ppm have a cross peak with the proton resonances around 8.14–8.04 ppm (anti- -isomer) and 7.94–7.92 ppm (syn-isomer) in the HSQC spectrum. These proton signals have good β-correlation with the carbon signals at 164.35 and 164.17 ppm in the HMBC spectrum. It is clear that the signals at 164.35 and 164.17 ppm belong to the carbonyl carbon (C-13) of anti- and syn-isomers of 4d. In the HSQC spectrum, the signals around 7.83–7.77 ppm have a cross peak with the 13C-signals at 112.38 and 112.31 ppm. In the HMBC spectrum, the same proton signals are in correlation with the quaternary carbon (C-4) signals at 127.54 ppm (anti-isomer) and 127.46 ppm (syn-isomer). These data show that the signals around 7.83–7.77 ppm belong to the olefinic protons attached to the olefinic car- bons (C-3) on benzofuran, which give signals at 112.38 and 112.31 ppm. The correlations in the HMBC spectrum show that the carbons giving the signals at 155.49 and 154.81 ppm, 148.81 and 148.51 ppm and 127.54 and 127.46 ppm belong to C-9, C-2 and C-4 of the anti- and syn-isomers, respectively. The sig- nals around 7.83–7.94 ppm have cross peaks with the 13C-signals at 123.64 ppm (anti-isomer) and 122.99 ppm (syn-isomer) in the HSQC spectrum and have α-correlation with the quaternary carbon signals at 155.49 and 154.81 ppm and 127.54 and 127.46 ppm in the HMBC spectrum. The protons giving the signals around 7.83–7.94 ppm are attached to C-5, which resonate at 123.64 ppm (anti- -isomer) and 122.99 ppm (syn-isomer). The quaternary carbon signals at 155.49 and 154.81 ppm and 148.81 and 148.51 ppm have α-correlation with the signals at 7.65–7.59 ppm in the HMBC spectrum, and these proton signals have cross peak with the 13C-signal at 113.48 ppm (anti-isomer) and 113.36 ppm (syn-iso- mer) in the HSQC spectrum. These data show that the signals around 7.65–7.59 ppm are due to the protons attached to C-8. Antibacterial activity The minimal inhibitory concentration (MIC) of the synthesized compounds was determined against S. aureus, E. coli and S. enterica subsp. enterica serovar Typhimurium using a standard broth dilution technique. All the MIC results are presented in Table II. The obtained data showed that the compounds were able to inhibit the growth of the selected microorganisms in vitro with MIC values between 32 and 128 µg mL–1. Among the synthesized compounds, 4e exhibited good activity against S. aureus and E. coli and 1 against S. enterica subsp. enterica serovar Typhimurium SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF DIKETOXIME DERIVATIVES 375 with an MIC value of 32 µg mL–1. The other compounds showed moderate activity against the tested microorganisms. TABLE II. Minimum inhibitory concentration (MIC / µg mL-1) of compounds 1–4; positive control: chloramphenicol Compound E. coli ATCC 25922 S. enterica NRRL 4420 S. aureus ATCC 6538 1 64 32 64 2 64 128 64 3 64 64 128 4a 64 128 128 4b 64 128 64 4c 128 128 128 4d 128 128 64 4e 32 64 32 Positive control 32 32 32 CONCLUSIONS In the present study, 1,1′-(2,5-thiophenediyl)bis[1-(2-benzofuranyl)metha- none] (2), the corresponding diketoxime (3) and the ether and ester derivatives (4a–e) of the diketoxime were designed and synthesized. The synthesized com- pounds 3 and 4a–e were mixtures of different isomers, such as syn-, anti- and amphi-isomers. Synthesized compounds were tested for antimicrobial activity against S. aureus, E. coli and S. enterica subsp. enterica serovar Typhimurium. Among the synthesized compounds, 1 and 4e showed good activity against E. coli (ATCC 25922), S. typhimurium (NRRL 4413) and S. aureus (ATCC 6538). The biological effects of 1–4 could be helpful in the design of more potent anti- bacterial agents for therapeutic use. SUPPLEMENTARY MATERIAL Analytical and spectral data, as well as the NMR spectra, of the synthesized compounds are available electronically at the pages of journal website: http://www.shd.org.rs/JSCS/, or from the corresponding author on request. Acknowledgment. The authors thank Firat University for financial support of this work. И З В О Д СИНТЕЗА, КАРАКТЕРИЗАЦИЈА И АНТИМИКРОБНА АКТИВНОСТ НОВИХ ДЕРИВАТА ДИКЕТОКСИМА КОЈИ САДРЖЕ БЕНЗОФУРАН И ТИОФЕН DEMET COSKUN1, SEHER GUR2 и MEHMET FATIH COSKUN1 1 University of Fırat, Faculty of Science, Department of Chemistry, 23119 Elazığ-Turkey и 2University of Fırat, Faculty of Science, Department of Biology, 23119 Elazığ-Turkey Описана је синтеза 1,1′-(2,5-тиофендиyл)бис[1-(2-бензофуранил)метанона] (2), одговарајућих дикетоксима (3) и етарских и естарских деривата дикетоксима (4а–е). Једињења су синтетисана у добром приносу. Одређена је минимална инхибиторна 376 COSKUN, GUR and COSKUN активност (MIC) синтетисаних једињења 1–4 према Salmonella enterica subsp. enterica serovar Тyphimurium, Escherichia coli и Staphylococcus aureus. Од синтетисаних једињења, деривати 1 и 4е показују добру активност према E.coli, S. enterica и S.aureus. (Примљено 17. маја, ревидирано 24 новембра, прихваћено 14. децембра 2016) REFERENCES 1. O. Oter, K. Ertekin, C, Kirilmis, M. Koca, M. Ahmedzade, Sens. Actuators, B 122 (2007) 450 2. F. Karatas, M. Koca, H. Kara, S. Servi, Eur. J. Med. Chem. 41 (2006) 664 3. R. W. Sabnis, D. W. Rangnekar, N. D. Sonawane, J. Heterocycl. Chem. 36 (1999) 333 4. A. M. Khalil, M. A. Berghot, E. Ghada, E. G. Abd, M. A. Gouda, Synth. Commun. 40 (2010) 1658 5. P. G. Costa Susana, E. Oliveira, C. Lodeiro, Tetrahedron Lett. 49 (2008) 5258 6. G. N. Schrauzer, Angew. Chem. Int. Ed. 15 (1976) 417 7. T. W. Thomas, A. E. Underhill, Chem. Soc. Rev. 1 (1972) 99 8. A. E. Underhill, D. M. Watkins, R. Pethig, Inorg. Nucl. Chem. Lett. 9 (1973) 1269 9. A. Chakravorty, Coord. Chem. Rev. 13 (1974) 1 10. K. Kurita, Polym. Degrad. Stab. 59 (1998) 117 11. N. K. Mathur, C. K. Narang, J. Chem. Educ. 67 (1990) 938 12. M. N. V. Ravi Kumar, React. Funct. Polym. 46 (2000) 1 13. A. Amalraj, R. Raghunathan, M. R. Sridevi Kumari, N. Raman, Bioorg. Med. Chem. 11 (2003) 407 14. I. G. Mobio, A. T. Soldatenkov, V. O. Federov, E. A. Ageev, N. D. Sergeeva, S. Lin, E. E. Stashenko, N. S. Prostakov, E. I. Andreeva, Khim.-Farm. Zh. 23 (1989) 421 15. R. V. Perumal, M. Adiraj, P. Shanmugapandiyan, Indian Drugs 38 (2001) 156 16. S. Balasubramanin, C. Ramalingan, G. Aridoss, S. Kabilan, Eur. J. Med. Chem. 40 (2005) 694 17. S. Balasubramanin, C. Ramalingan, G. Aridoss, P. Parthiban, S. Kabilan, Med. Chem. Res. 13 (2004) 297 18. C. Ramalingan, S. Balasubramanin, S. Kabilan, M. Vasudevan, Eur. J. Med. Chem. 39 (2004) 527 19. C. Ramalingan, S. Balasubramanin, S. Kabilan, M. Vasudevan, Med. Chem. Res. 12 (2003) 41 20. M. Srinivasan, S. Perumal, S. Selvaraj, Chem. Pharm. Bull. 54 (2006) 795 21. K. Narayanan, M. Shanmugan, S. Jothivel, S. Kabilan, Bioorg. Med. Chem. Lett. 22 (2012) 6602 22. J. V. Dijk, J. M. A. Zwagemakers, J. Med. Chem. 20 (1977) 1199 23. A. Bishnoi, S. Singh, A. K. Tiwari, A. Sethi, C. M. Tripathi, Med. Chem. 9 (2013) 45 24. A. Fravolini, F. Schiaffella, G. Orzalesi, R. Selleri. I. Volpato, Eur. J. Med. Chem. 13 (1978) 347 25. S. J. Burditt, P. B. Hamilton, Poultry Sci. 62 (1983) 2183 26. D. P. Jindal, R. Chattopadhaya, S. Guleria, R. Gupta, Eur. J. Med. Chem. 38 (2003) 1025 27. B. Premalatha, D. Bhakiaraj, B. Chellakili, M. Gopalakrishnan, J. Pharm. Res. 6 (2013) 730 28. N. O. Iskeleli, C. Kazak, C. Kirilmis, M. Koca, Acta Crystallogr., E 61 (2005) 1212 29. C. Kirilmis, M. Koca, A. Cukurovali, M. Ahmedzade, C. Kazaz, Molecules 10 (2005) 1399 30. Y. Miyahara, J. Heterocycl. Chem. 16 (1979) 1147 SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF DIKETOXIME DERIVATIVES 377 31. F. Yuksel, A. G. Gurek, M. Durmus, I. Gurol, V. Ahsen, E. Jeanneau, D. Luneau, Inorg. Chim. Acta 361 (2008) 2225 32. G. Massolini, M. L. Carmellino, A. Baruffini, Farmaco 49 (1994) 747 33. H. A. Dondas, R. Grigg, J. Markandu, T. Perrior, T. Suzuki, S. Thibault, W. A. Thomas, M. Thornton-Pett, Tetrahedron 58 (2002) 161 34. C. B. Li, H. Zhang, Y. Cui, S. M. Zhang, Z. Y. Zhao, M. C. K. Choi, A. S. C. Chan, Synth. Commun. 33 (2003) 543 35. A. B. Zaitsev, A. M., Vasil'tsov, E. Y. Schmidt, A. L. Mikhaleva, L. V. Morozova, A. V. Afonin, I. A. Ushakov, B. A. Trofimov, Tetrahedron 58 (2002) 10043 36. H. Sharghi, M. H. Sarvari, Synlett 1 (2001) 99 37. A. Gül, O. Bekaroglu, J. Chem. Soc. Dalton. Trans. 12 (1983) 2537 38. V. Ahsen, F. Gokceli, O. Bekaroglu, J. Chem. Soc. Dalton Trans. 8 (1987) 1827 39. A. Nakamura, A. Konishi, S. Otsuka, J. Chem. Soc. Dalton. Trans. 3 (1979) 488 40. M. S. Ma, R. J. Angelici, Inorg. Chem. 19 (1980) 363. << /ASCII85EncodePages false /AllowTransparency false /AutoPositionEPSFiles true /AutoRotatePages /None /Binding /Left /CalGrayProfile (Dot Gain 20%) /CalRGBProfile (sRGB IEC61966-2.1) /CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2) /sRGBProfile (sRGB IEC61966-2.1) /CannotEmbedFontPolicy /Error /CompatibilityLevel 1.4 /CompressObjects /Tags /CompressPages true /ConvertImagesToIndexed true /PassThroughJPEGImages true /CreateJobTicket false /DefaultRenderingIntent /Default /DetectBlends true /DetectCurves 0.0000 /ColorConversionStrategy /CMYK /DoThumbnails false /EmbedAllFonts true /EmbedOpenType false /ParseICCProfilesInComments true /EmbedJobOptions true /DSCReportingLevel 0 /EmitDSCWarnings false /EndPage -1 /ImageMemory 1048576 /LockDistillerParams false /MaxSubsetPct 100 /Optimize true /OPM 1 /ParseDSCComments true /ParseDSCCommentsForDocInfo true /PreserveCopyPage true /PreserveDICMYKValues true /PreserveEPSInfo true /PreserveFlatness true /PreserveHalftoneInfo false /PreserveOPIComments true /PreserveOverprintSettings true /StartPage 1 /SubsetFonts true /TransferFunctionInfo /Apply /UCRandBGInfo /Preserve /UsePrologue false /ColorSettingsFile () /AlwaysEmbed [ true ] /NeverEmbed [ true ] /AntiAliasColorImages false /CropColorImages true /ColorImageMinResolution 300 /ColorImageMinResolutionPolicy /OK /DownsampleColorImages true /ColorImageDownsampleType /Bicubic /ColorImageResolution 300 /ColorImageDepth -1 /ColorImageMinDownsampleDepth 1 /ColorImageDownsampleThreshold 1.50000 /EncodeColorImages true /ColorImageFilter /DCTEncode /AutoFilterColorImages true /ColorImageAutoFilterStrategy /JPEG /ColorACSImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /ColorImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000ColorACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000ColorImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 300 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /GrayImageDict << /QFactor 0.15 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000GrayACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /JPEG2000GrayImageDict << /TileWidth 256 /TileHeight 256 /Quality 30 >> /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 1200 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict << /K -1 >> /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile () /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False /CreateJDFFile false /Description << /ARA /BGR /CHS /CHT /CZE /DAN /DEU /ESP /ETI /FRA /GRE /HEB /HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke. Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 5.0 i kasnijim verzijama.) /HUN /ITA /JPN /KOR /LTH /LVI /NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit. De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 5.0 en hoger.) /NOR /POL /PTB /RUM /RUS /SKY /SLV /SUO /SVE /TUR /UKR /ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing. Created PDF documents can be opened with Acrobat and Adobe Reader 5.0 and later.) >> /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ << /AsReaderSpreads false /CropImagesToFrames true /ErrorControl /WarnAndContinue /FlattenerIgnoreSpreadOverrides false /IncludeGuidesGrids false /IncludeNonPrinting false /IncludeSlug false /Namespace [ (Adobe) (InDesign) (4.0) ] /OmitPlacedBitmaps false /OmitPlacedEPS false /OmitPlacedPDF false /SimulateOverprint /Legacy >> << /AddBleedMarks false /AddColorBars false /AddCropMarks false /AddPageInfo false /AddRegMarks false /ConvertColors /ConvertToCMYK /DestinationProfileName () /DestinationProfileSelector /DocumentCMYK /Downsample16BitImages true /FlattenerPreset << /PresetSelector /MediumResolution >> /FormElements false /GenerateStructure false /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles false /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /DocumentCMYK /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /UseDocumentProfile /UseDocumentBleed false >> ] >> setdistillerparams << /HWResolution [2400 2400] /PageSize [612.000 792.000] >> setpagedevice